These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)]. Ogura T Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203 [No Abstract] [Full Text] [Related]
4. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas]. Richter J; Duchková H; Kubíková M Cas Lek Cesk; 1975 Sep; 114(39):1201-3. PubMed ID: 1182748 [No Abstract] [Full Text] [Related]
5. [Regression of melanoma metastases after immunological therapy]. Malek-Mansour S; Castermans-Elias S; Lapière CM Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482 [No Abstract] [Full Text] [Related]
6. Introduction: Immunotherapy of cancer in man, a reality. Klein E Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961 [No Abstract] [Full Text] [Related]
7. [Immunotherapy of melanoma (proceedings)]. Bolund C Lakartidningen; 1978 Dec; 75(49):4598. PubMed ID: 723350 [No Abstract] [Full Text] [Related]
9. [Use of immunotherapy in the treatment of malignant melanoma of the skin]. Kristensen E Ugeskr Laeger; 1976 Feb; 138(8):468-73. PubMed ID: 1258215 [No Abstract] [Full Text] [Related]
10. Adjuvant combination immunotherapy (BCG and levamisole) in malignant melanoma. Dandapat MC; Mohapatra SK; Patra SK Indian J Cancer; 1985 Jun; 22(2):100-7. PubMed ID: 3842124 [No Abstract] [Full Text] [Related]
11. [Current aspects of melanoma research. II. Immunotherapy]. Wätzig V Dermatol Monatsschr; 1977 May; 163(5):359-66. PubMed ID: 881082 [No Abstract] [Full Text] [Related]
12. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V; Knopf B Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442 [TBL] [Abstract][Full Text] [Related]